Neuroleptic Malignant Syndrome
Showing 1–12 of 24 results
When there is suspicion for neuroleptic malignant syndrome, prompt medical therapy and discontinuation of the offending agent are crucial. This report presents an atypical case of this potentially fatal adverse drug reaction.
Partially Treated Catatonia and Incipient Neuroleptic Malignant Syndrome: A Challenging Presentation
Neuroleptic malignant syndrome (NMS) is a life-threatening condition associated with use of psychotropic medications. This report presents a case of incipient NMS in a patient who developed catatonia during treatment with lorazepam and paliperidone.
Neuroleptic malignant syndrome (NMS) is often associated with use of typical antipsychotics, but antiepileptics have also been implicated. This report describes the case of an elderly man with schizophrenia who experienced NMS with valproate.
A patient develops catatonia after resolution of neuroleptic malignant syndrome. Is ECT a possible treatment option?
Psoas Abscess as a Differential Diagnosis of Neuroleptic Malignant Syndrome in a Schizoaffective Disorder Patient With Catatonic Symptoms
Diagnosis of NMS is complicated by coexisting pathologies that have a similar clinical picture. This report describes a woman with schizoaffective disorder who presented with a psychotic episode and developed an infection. NMS was initially hypothesized as a diagnosis, but, ultimately, psoas abscess appeared to be responsible for her clinical worsening.
Neuroleptic malignant syndrome is a rare but potentially serious reaction to antipsychotic medications. Early recognition and a low index of suspicion are required as the presentation shares symptoms with other disorders, which is further compounded by a lack of definitive diagnostic criteria. Here, read the case of Mr A, whose health began to deteriorate after treatment for first-episode psychosis.
Neuroleptic malignant syndrome is a rare but potentially lethal consequence of the use of antipsychotic medications that requires familiarity with the condition to rapidly recognize its onset and appropriately intervene. This review provides an overview of neuroleptic malignant syndrome for the general practitioner with the most up-to-date information on etiology, workup, and management.
Managing Manic Delirium in Bipolar Disorder With Features of Mania, Catatonia, and Neuroleptic Malignant Syndrome
Bipolar disorder is a chronic illness characterized by episodes of mania and depression with or without psychotic features. Severe mood episodes and their treatment can result in significant morbidity including manic delirium, catatonia, and neuroleptic malignant syndrome. Read this case of a patient who exhibited this continuum of symptomatology.
Neuroleptic malignant syndrome is a severe idiosyncratic and potentially life-threatening adverse effect of antipsychotic therapy characterized by fever, rigidity, altered mental status, creatine kinase elevation, and autonomic instability. Here, read about the case of a patient who developed neuroleptic malignant syndrome after treatment with multiple antipsychotics, including an early administration of risperidone long-acting injection.